Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 89

Similar articles for PubMed (Select 23588075)


Fine-tuning the p53 response to DNA damage: a new piece in the puzzle.

Polo SE.

Cell Cycle. 2013 May 1;12(9):1337-8. doi: 10.4161/cc.24669. Epub 2013 Apr 15. No abstract available.


ATM targets hnRNPK to control p53.

Blasius M, Bartek J.

Cell Cycle. 2013 Apr 15;12(8):1162-3. doi: 10.4161/cc.24485. Epub 2013 Apr 2. No abstract available.


ATM-dependent phosphorylation of heterogeneous nuclear ribonucleoprotein K promotes p53 transcriptional activation in response to DNA damage.

Moumen A, Magill C, Dry KL, Jackson SP.

Cell Cycle. 2013 Feb 15;12(4):698-704. doi: 10.4161/cc.23592. Epub 2013 Jan 23.


hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage.

Moumen A, Masterson P, O'Connor MJ, Jackson SP.

Cell. 2005 Dec 16;123(6):1065-78.


Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression.

Kang J, Ferguson D, Song H, Bassing C, Eckersdorff M, Alt FW, Xu Y.

Mol Cell Biol. 2005 Jan;25(2):661-70.


Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage.

Pereg Y, Shkedy D, de Graaf P, Meulmeester E, Edelson-Averbukh M, Salek M, Biton S, Teunisse AF, Lehmann WD, Jochemsen AG, Shiloh Y.

Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5056-61. Epub 2005 Mar 23.


Requirement of ATM for rapid p53 phosphorylation at Ser46 without Ser/Thr-Gln sequences.

Kodama M, Otsubo C, Hirota T, Yokota J, Enari M, Taya Y.

Mol Cell Biol. 2010 Apr;30(7):1620-33. doi: 10.1128/MCB.00810-09. Epub 2010 Feb 1.


ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage.

Dornan D, Shimizu H, Mah A, Dudhela T, Eby M, O'rourke K, Seshagiri S, Dixit VM.

Science. 2006 Aug 25;313(5790):1122-6.


FOXO3 signalling links ATM to the p53 apoptotic pathway following DNA damage.

Chung YM, Park SH, Tsai WB, Wang SY, Ikeda MA, Berek JS, Chen DJ, Hu MC.

Nat Commun. 2012;3:1000. doi: 10.1038/ncomms2008. Erratum in: Nat Commun. 2013;4:1520.


Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity.

Yoshida M, Shiojima I, Ikeda H, Komuro I.

J Mol Cell Cardiol. 2009 Nov;47(5):698-705. doi: 10.1016/j.yjmcc.2009.07.024. Epub 2009 Aug 3.


Imperfect correlation between p53 dysfunction and deletion of TP53 and ATM in chronic lymphocytic leukaemia.

Carter A, Lin K, Sherrington PD, Atherton M, Pearson K, Douglas A, Burford A, Brito-Babapulle V, Matutes E, Catovsky D, Pettitt AR.

Leukemia. 2006 Apr;20(4):737-40. No abstract available.


Activation of interferon-stimulated genes by gamma-ray irradiation independently of the ataxia telangiectasia mutated-p53 pathway.

Sugihara T, Murano H, Nakamura M, Ichinohe K, Tanaka K.

Mol Cancer Res. 2011 Apr;9(4):476-84. doi: 10.1158/1541-7786.MCR-10-0358. Epub 2011 Feb 25.


Defective p53 response and apoptosis associated with an ataxia-telangiectasia-like phenotype.

Gueven N, Becherel OJ, Birrell G, Chen P, DelSal G, Carney JP, Grattan-Smith P, Lavin MF.

Cancer Res. 2006 Mar 15;66(6):2907-12.


BRCA1-BARD1 complexes are required for p53Ser-15 phosphorylation and a G1/S arrest following ionizing radiation-induced DNA damage.

Fabbro M, Savage K, Hobson K, Deans AJ, Powell SN, McArthur GA, Khanna KK.

J Biol Chem. 2004 Jul 23;279(30):31251-8. Epub 2004 May 24.


E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis.

Powers JT, Hong S, Mayhew CN, Rogers PM, Knudsen ES, Johnson DG.

Mol Cancer Res. 2004 Apr;2(4):203-14.


p53: guardian of the genome and policeman of the oncogenes.

Efeyan A, Serrano M.

Cell Cycle. 2007 May 2;6(9):1006-10. Epub 2007 May 28. Review.


Differential roles of ATR and ATM in p53, Chk1, and histone H2AX phosphorylation in response to hyperoxia: ATR-dependent ATM activation.

Kulkarni A, Das KC.

Am J Physiol Lung Cell Mol Physiol. 2008 May;294(5):L998-L1006. doi: 10.1152/ajplung.00004.2008. Epub 2008 Mar 14.


Dual regulation of Cdc25A by Chk1 and p53-ATF3 in DNA replication checkpoint control.

Demidova AR, Aau MY, Zhuang L, Yu Q.

J Biol Chem. 2009 Feb 13;284(7):4132-9. doi: 10.1074/jbc.M808118200. Epub 2008 Dec 7.


BID as a double agent in cell life and death.

Gross A.

Cell Cycle. 2006 Mar;5(6):582-4. Epub 2006 Mar 15. Review.


MYCN sensitizes human neuroblastoma to apoptosis by HIPK2 activation through a DNA damage response.

Petroni M, Veschi V, Prodosmo A, Rinaldo C, Massimi I, Carbonari M, Dominici C, McDowell HP, Rinaldi C, Screpanti I, Frati L, Bartolazzi A, Gulino A, Soddu S, Giannini G.

Mol Cancer Res. 2011 Jan;9(1):67-77. doi: 10.1158/1541-7786.MCR-10-0227. Epub 2010 Dec 20.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk